Statistics Collaborative, Inc. (SCI) specializes in providing biostatistical consulting services for clients developing drugs, biologics, and devices. While our primary expertise lies in clinical trials, we also work with epidemiological studies, preclinical studies, and non-clinical research. Our staff have years of experience collaborating with researchers in industry, non-profit organizations, government agencies, and academic settings.
We have a wide range of statistical expertise including trial design, reporting for Data Monitoring Committees, creating randomization schemes, data analysis, and consultation for FDA presentations. We work in a wide range of therapeutic areas, with special emphasis on cardiovascular disease, infectious disease, orphan diseases, and vaccines.
SCI staff helps our clients develop research programs with scientific rigor and statistical validity. We are committed to maintaining the highest scientific and ethical standards while providing timely and cost-effective services.